1. Home
  2. News
  3. Vivo Bio Tech Ltd.
  4. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
More Vivo Bio Tech Ltd. news
Vivo Bio Tech Ltd.BSE: VIVOBIOT

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Apr 21, 2025 at 2:29 AM EDT · Issued by Vivo Bio Tech Ltd. via BSE India

Filed with BSE · Apr 21, 2025 at 2:29 AM EDT

On 6ix: 6ix.com/news/disclosures-under-reg-292-of-sebi-sast-regulations-2011-430

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kompella Lopa Mudra

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Vivo Bio Tech Ltd. on 6ix

Earlier from Vivo Bio Tech

  • Vivo Bio Tech Ltd. Press Release Apr 11 2025Apr 11, 2025
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 11, 2025
  • Vivo Bio Tech Ltd. Press Release Apr 08 2025Apr 8, 2025
  • Announcement under Regulation 30 (LODR)-AllotmentApr 8, 2025
  • Vivo Bio Tech Ltd. Press Release Mar 29 2025Mar 29, 2025

Later from Vivo Bio Tech

  • Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 6, 2025
  • Vivo Bio Tech Ltd. Press Release May 06 2025May 6, 2025
  • Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 12, 2025
  • Vivo Bio Tech Ltd. Press Release May 12 2025May 12, 2025
  • Integrated Filing (Financial)May 19, 2025
All Vivo Bio Tech news releases↗

Follow Vivo Bio Tech into a list and get an email when it puts out news.

Follow Vivo Bio Tech
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer